NCT03527888 2019-05-21Study of Anlotinib in Patients With Primary Malignant Bone TumorsChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 2 Unknown40 enrolled
NCT02982486 2017-11-01A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial CarcinomaAssaf-Harofeh Medical CenterPhase 2 Unknown60 enrolled